Asbestos Lawsuit History: Borel, Manville, and 524(g) Trusts

The history of asbestos lawsuits in the United States spans roughly a century, beginning with scattered worker injury claims in the 1920s and continuing through today’s active dockets of mesothelioma and talc cases. Along the way, a single 1973 appellate decision opened the door to mass tort litigation, dozens of major manufacturers filed for bankruptcy, Congress wrote a special section of the bankruptcy code just for asbestos, and more than 60 trust funds were established to pay victims. Understanding that arc matters because it determines who a claimant can sue today, where the money comes from, and how much of it actually reaches the people who are sick.

The First Four Decades of Claims Went Nowhere

Medical evidence linking asbestos dust to fatal lung disease was published in the 1920s, and the British government’s 1930 Merewether Report concluded that asbestos-caused lung scarring could “of itself lead to complete disablement and to a fatal termination.”1H.M. Stationery Office. Report on Effects of Asbestos Dust on the Lungs and Dust Suppression in the Asbestos Industry American textile and insulation workers began filing injury claims shortly after, but almost none of them succeeded.

The reasons were structural. No federal or state regulations governed industrial asbestos exposure. Companies denied that the medical literature proved anything. Courts had no framework for connecting workplace dust inhaled years earlier to a chronic disease diagnosed later. For roughly four decades, cases either settled for trivial amounts or were dismissed outright.

Borel v. Fibreboard Changed the Legal Theory

In 1973, the Fifth Circuit decided Borel v. Fibreboard Paper Products Corp., a lawsuit brought by an industrial insulation worker named Clarence Borel against several asbestos insulation manufacturers for failing to warn him of the dangers of their products. The jury found for Borel on a strict liability theory, and the appellate court affirmed.2Justia. Borel v. Fibreboard Paper Products Corporation

Strict liability was the key. The court held that manufacturers had an ongoing duty to warn of foreseeable dangers in their products, even when the resulting harm appeared decades after exposure. That reasoning cut the ground out from under the industry’s main defense, which had been that workers assumed the risks of their jobs. Lawyers across the country then began filing product liability suits instead of relying on workers’ compensation, and discovery in those cases turned up internal company documents showing that executives had known about the health risks for years before issuing warnings. Jury awards grew.

Johns-Manville and the Bankruptcy Wave

By the early 1980s, defendants faced tens of thousands of pending claims. In August 1982, Johns-Manville Corporation, then the world’s largest asbestos producer, filed for Chapter 11 bankruptcy. The company was still profitable, but projected litigation costs dwarfed its ability to pay.3Manville Trust. History

Dozens of other asbestos defendants followed over the next two decades. This is why so many familiar manufacturer names no longer exist as lawsuit targets: their liabilities were transferred, through bankruptcy, into dedicated trust funds.

MDL 875 and the Failed Attempt at a Global Settlement

In 1991, the Judicial Panel on Multidistrict Litigation consolidated federal asbestos cases in the Eastern District of Pennsylvania as MDL 875.4Eastern District of Pennsylvania. MDL 875 In Re: Asbestos Products Liability Litigation In 1993, attorneys proposed a class action settlement covering an estimated 25,000 to 2,000,000 exposed individuals, which would have resolved claims against members of the Center for Claims Resolution in a single stroke.

It never happened. The Third Circuit rejected the class, and in 1997 the U.S. Supreme Court agreed in Amchem Products, Inc. v. Windsor, holding that the proposed class failed the requirements of Federal Rule of Civil Procedure 23 because the differences among claimants were too vast for one settlement to treat them fairly.4Eastern District of Pennsylvania. MDL 875 In Re: Asbestos Products Liability Litigation The MDL still carries roughly 3,000 active cases. The lesson from Amchem shapes everything that followed: asbestos claims are too individualized for any single resolution, so they get handled claimant by claimant.

How Section 524(g) Trust Funds Work

With traditional litigation unable to keep pace, Congress stepped in. The Bankruptcy Reform Act of 1994 added Section 524(g) to the federal bankruptcy code, written specifically for asbestos defendants. A reorganizing company can transfer its asbestos liabilities into a court-supervised trust, and in exchange for adequately funding that trust, the company receives a permanent injunction protecting it from all future asbestos lawsuits.5Office of the Law Revision Counsel. 11 U.S. Code 524 – Effect of Discharge

Each trust is a dedicated pool of money for people diagnosed with asbestos-related diseases. To make limited assets last across decades of future claims, trusts pay only a percentage of each claim’s scheduled value. The Johns-Manville Trust, the oldest and largest, currently pays around 5% of scheduled values. Other major trusts pay between 6% and 8%. A mesothelioma claim with a scheduled value of several hundred thousand dollars can produce a check that is much smaller than claimants expect.

Qualifying requires meeting specific medical and exposure criteria. Claimants submit a documented work history showing contact with the defendant’s products, together with a medical diagnosis supported by pathology reports or imaging read by a certified specialist.6USG Asbestos Trust. IR Medical Requirements Scheduled values vary by disease, with mesothelioma at the top and non-malignant conditions at lower tiers.7Armstrong World Asbestos Trust. Armstrong World Asbestos Trust – IR Medical Requirements Payment percentages are recalculated as asset and claim projections change, and they tend to drop over time.

The Garlock Decision and the Fight Over Trust Transparency

The trust system created a side effect. Plaintiffs could file claims against multiple trusts while also pursuing lawsuits against solvent defendants, sometimes telling different exposure stories in different forums. In 2014, the bankruptcy court in In re Garlock Sealing Technologies found what it called a “startling pattern of misrepresentation,” in which plaintiffs and their attorneys withheld evidence of trust claims while pursuing jury trials against Garlock. The court concluded that this had “unfairly inflated” recoveries against the company.

Garlock sparked a push for federal transparency legislation. The proposed Furthering Asbestos Claim Transparency (FACT) Act would have required Section 524(g) trusts to publish regular reports on claims received and paid, and would have let civil defendants demand that information. The bill passed the House but stalled in the Senate, and no federal transparency mandate was enacted. Several states have adopted their own disclosure rules requiring plaintiffs to identify trust claims before trial against a solvent defendant.

Why Old Exposures Still Produce Timely Lawsuits

Asbestos diseases often take 20 to 50 years to appear after exposure. If the statute of limitations started running at the time of exposure, almost every claim would expire before the victim knew anything was wrong. The discovery rule solves this by starting the clock when the person is diagnosed with an asbestos-related disease, not when the exposure happened. For wrongful death claims, the clock typically runs from the date of death.

The filing window after that trigger depends on state law and ranges from one to six years, with most states falling between two and three. Which state’s deadline applies can itself be a complicated question, since the relevant jurisdiction may be where the exposure occurred, where the person lived, or where the defendant was headquartered. Missing the deadline in the correct state almost always ends the case, so this is where avoidable mistakes most often happen.

Where Asbestos Lawsuits Are Being Filed Today

As the original manufacturers moved into trusts, litigation shifted toward secondary defendants: companies that incorporated asbestos into finished products or maintained workplaces where it was present. Automotive parts manufacturers, retailers, equipment makers, and building owners now routinely appear as named defendants.

The biggest modern expansion is talcum powder litigation. Plaintiffs allege that talc-based consumer products contained trace asbestos contamination. As of early 2026, roughly 69,000 plaintiffs are consolidated in what has become the country’s largest active multidistrict litigation. A court-appointed special master has recommended allowing expert testimony linking genital talc use to ovarian cancer, finding that epidemiological studies show a statistically significant association. Individual talc-asbestos verdicts have been large, including a $1.56 billion award for a single mesothelioma plaintiff in Baltimore, though some awards have been reduced on appeal.

Scientific advances keep adding new defendants. Electron microscopy and mineralogical analysis can now trace specific fiber types to particular product lines, letting plaintiffs tie disease to a specific company’s product with a precision that was not possible in earlier decades. For anyone diagnosed with an asbestos-related disease today, the practical consequence of this century of litigation is that there are usually two parallel paths: filing claims with the relevant trusts for defendants that have reorganized, and filing civil suits against solvent companies still in the supply chain.